China · Delayed Price · Currency is CNY Aurisco Pharmaceutical Statistics
Total Valuation
SHA:605116 has a market cap or net worth of CNY 8.05 billion. The enterprise value is 8.10 billion.
| Market Cap | 8.05B |
| Enterprise Value | 8.10B |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Jun 20, 2025 |
Share Statistics
SHA:605116 has 403.41 million shares outstanding. The number of shares has increased by 3.37% in one year.
| Current Share Class | 403.41M |
| Shares Outstanding | 403.41M |
| Shares Change (YoY) | +3.37% |
| Shares Change (QoQ) | -3.58% |
| Owned by Insiders (%) | 74.50% |
| Owned by Institutions (%) | 2.92% |
| Float | 89.55M |
Valuation Ratios
The trailing PE ratio is 20.72 and the forward PE ratio is 14.68.
| PE Ratio | 20.72 |
| Forward PE | 14.68 |
| PS Ratio | 4.78 |
| PB Ratio | 2.96 |
| P/TBV Ratio | 3.15 |
| P/FCF Ratio | 60.87 |
| P/OCF Ratio | 16.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.13, with an EV/FCF ratio of 61.26.
| EV / Earnings | 20.58 |
| EV / Sales | 4.81 |
| EV / EBITDA | 13.13 |
| EV / EBIT | 16.81 |
| EV / FCF | 61.26 |
Financial Position
The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.36.
| Current Ratio | 4.22 |
| Quick Ratio | 2.80 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 1.57 |
| Debt / FCF | 7.33 |
| Interest Coverage | 13.50 |
Financial Efficiency
Return on equity (ROE) is 15.26% and return on invested capital (ROIC) is 15.40%.
| Return on Equity (ROE) | 15.26% |
| Return on Assets (ROA) | 7.40% |
| Return on Invested Capital (ROIC) | 15.40% |
| Return on Capital Employed (ROCE) | 12.78% |
| Weighted Average Cost of Capital (WACC) | 2.66% |
| Revenue Per Employee | 831,562 |
| Profits Per Employee | 194,333 |
| Employee Count | 2,026 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 1.13 |
Taxes
In the past 12 months, SHA:605116 has paid 60.18 million in taxes.
| Income Tax | 60.18M |
| Effective Tax Rate | 13.26% |
Stock Price Statistics
The stock price has decreased by -5.18% in the last 52 weeks. The beta is -0.30, so SHA:605116's price volatility has been lower than the market average.
| Beta (5Y) | -0.30 |
| 52-Week Price Change | -5.18% |
| 50-Day Moving Average | 24.58 |
| 200-Day Moving Average | 24.53 |
| Relative Strength Index (RSI) | 26.91 |
| Average Volume (20 Days) | 3,388,851 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:605116 had revenue of CNY 1.68 billion and earned 393.72 million in profits. Earnings per share was 0.96.
| Revenue | 1.68B |
| Gross Profit | 963.86M |
| Operating Income | 482.23M |
| Pretax Income | 453.90M |
| Net Income | 393.72M |
| EBITDA | 610.70M |
| EBIT | 482.23M |
| Earnings Per Share (EPS) | 0.96 |
Balance Sheet
The company has 917.17 million in cash and 969.50 million in debt, with a net cash position of -52.32 million or -0.13 per share.
| Cash & Cash Equivalents | 917.17M |
| Total Debt | 969.50M |
| Net Cash | -52.32M |
| Net Cash Per Share | -0.13 |
| Equity (Book Value) | 2.72B |
| Book Value Per Share | 6.74 |
| Working Capital | 1.55B |
Cash Flow
In the last 12 months, operating cash flow was 484.02 million and capital expenditures -351.74 million, giving a free cash flow of 132.29 million.
| Operating Cash Flow | 484.02M |
| Capital Expenditures | -351.74M |
| Depreciation & Amortization | 128.47M |
| Net Borrowing | -23.34M |
| Free Cash Flow | 132.29M |
| FCF Per Share | 0.33 |
Margins
Gross margin is 57.21%, with operating and profit margins of 28.62% and 23.37%.
| Gross Margin | 57.21% |
| Operating Margin | 28.62% |
| Pretax Margin | 26.94% |
| Profit Margin | 23.37% |
| EBITDA Margin | 36.25% |
| EBIT Margin | 28.62% |
| FCF Margin | 7.85% |
Dividends & Yields
This stock pays an annual dividend of 0.34, which amounts to a dividend yield of 1.71%.
| Dividend Per Share | 0.34 |
| Dividend Yield | 1.71% |
| Dividend Growth (YoY) | 31.82% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 31.50% |
| Buyback Yield | -3.37% |
| Shareholder Yield | -1.65% |
| Earnings Yield | 4.89% |
| FCF Yield | 1.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:605116 has an Altman Z-Score of 5.48 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.48 |
| Piotroski F-Score | 4 |